GUSTAVO RIVERO

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology WASHINGTON, DC NPI 1790736155

General Payments — all program years on this page

$32,588.77

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 60
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $506.98 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $461.7114
Education $45.271

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $8,811.5015
2019 $18,905.4114
2020 $1,064.932
2021 $1,296.972
2022 $1,760.997
2023 $241.995
2024 $506.9815

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087300443 Novartis Pharmaceuticals Corporation $20.70 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089474887 Daiichi Sankyo Inc. $83.38 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089474891 Daiichi Sankyo Inc. $28.90 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101113502 Celgene Corporation $29.94 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105954426 ABBVIE INC. $19.08 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116303541 GlaxoSmithKline, LLC. $21.01 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131693476 Legend Biotech USA Inc. $35.86 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131693553 Legend Biotech USA Inc. $28.11 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139336346 Astellas Pharma US Inc $23.00 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139772364 GENZYME CORPORATION $39.05 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139772390 GENZYME CORPORATION $43.44 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142086962 Teleflex LLC $29.62 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145201518 Rigel Pharmaceuticals, Inc. $24.37 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145208825 Rigel Pharmaceuticals, Inc. $35.25 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154021489 Apellis Pharmaceuticals, Inc. $45.27 09/30/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.